Current synthetic inhibitors of human neutrophil elastase

Bibliography

• SINHA S, WATOREK W, KARR S, GILES J, BODE W, TRAVIS J: Primary structure of human neutrophil elastase. Proc. Nat] Acad. Sci. USA (1987) 84:2228–2232.
   PubMed Web of Science ®Google Scholar
• BODE W, MEYER E JR, POWERS JC: Human leukocyte and porcine pancreatic elastase: x-ray crystal structures, mechanism, substrate specificity and mechanism-based inhibitors. Biochemistry (1989) 28(5):1951–1963.
   PubMed Web of Science ®Google Scholar
• JANOFF A, BLONDIN J: The effect of human granulocyte elastase on bacterial suspensions. Lab. Invest. (1973) 29(4):454.
   PubMedGoogle Scholar
• SANDHAUS RA: Elastase may play a central role in neutrophil migration through connective tissue. In: Pulmonary emphysema and proteolysis Taylar JC, Mittman C (Eds.), Academic Press, New York, USA (1987):227–233.
   Google Scholar
• VASSALLI JD, GRANELLI-PIPERNO A, GRISCELLI C, REICH E: Specific protease deficiency in polymorphonuclear leukocyte of Chediak-Higashi syndrome and beige mice. J Exp. Med. (1979) 147:1285–1290.
   Google Scholar
• MCGOWAN SE, MURRAY JJ: Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. Am. Rev. Respir: Dis. (1987) 135:1286–1293.
   PubMed Web of Science ®Google Scholar
• MCDONALD JA, KELLEY DG: Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol. Chem. (1980) 225(18):8848–8858.
   Google Scholar
• MAINARDI CL, HASTY DL, SEYER JM, KANG AH: Specific cleavage of human Type III collagen by human polymorphonuclear leukocyte elastase. Biol. Chem. (1980) 225(24):12006–12010.
   Google Scholar
• BIETH G: Elastase: catalytic and biological properties. In: Regulation of matrix accumulation. Mecham RP (Eds.), Academic Press, New York, USA (1986):217–306.
   Google Scholar
• TRAVIS J, DUBIN A, POTEMPA J, WATOREK W, KURDOWSKA A: Neutrophil proteinases. Ann. NY Acad. Sci. (1991) 624:81–86.
   PubMedGoogle Scholar
• FARLEY D, FALLER B, NICK H: Therapeutic protein inhibitors of elastase. Drugs Pharm. Sri. (1997) 84:305–335.
   Google Scholar
• •A comphrehensive review of therapeutic properties of elastase inhibitor.
   Google Scholar
• SOMMERHOFF CP, NADEL JA, BASBAUM CB, CAUGHEY GH: Neutrophil elastase and cathepsin G stimulate secretion from bovine airway gland serious cells. J Cell Invest. (1990) 85:682–689.
   PubMed Web of Science ®Google Scholar
• SMALLMAN LA, HILL SL, STOCKLEY RA: Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine protease effect. Thorax (1984) 39:663–667.
   PubMed Web of Science ®Google Scholar
• KEATINGS VM, COLLINS PD, SCOTT DM, BAMES PJ: Differences in interleukin-8 and tumour necrosis factor in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J Respir. Grit. Care Med. (1996) 153:530–534.
   PubMed Web of Science ®Google Scholar
• RICHMAN-EISENSTAT JBY, JORENSPG, HEBERT CA, UEKI I, NADEL JA: Interleukin-8, an important chemattractant in sputum of patients with chronic inflammatory airway diseases. Am. J. Physic] (1993) 264:L413–L418.
   Google Scholar
• SALVA PS, DOYLE NA, GRAHAM L, EIGEN H, DOERSCHUK CM: TNF-a, IL-8, soluble ICAM-1 and neutrophils in sputum of cystic fibrosis patients. Pediatr. Pulmonol (1996) 21:11–19.
   PubMedGoogle Scholar
• HEADLEY AS, TOLLEY E, MEDURI GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest (1997) 111(5):1306–1321.
   PubMedGoogle Scholar
• BAGGIOLINI M, WALZ A, KUNKEL SL: Neutrophil-activating peptide-1/interleukin- 8, a novel cytokine that activates neutrophils. j Clin. Invest. (1989) 84:1045–1049.
   PubMed Web of Science ®Google Scholar
• TATE RM, REPINE JE: Neutrophils and the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am. Rev Respir. Dis. (1983) 128:552–559.
   PubMed Web of Science ®Google Scholar
• WEILAND JE, DAVIS WB, HOLTER JF, MOHAMMED JR, DORINSKY PM, GADEK JE: Lung neutrophils in the adult respiratory distress syndrome. Am. Rev Respir Dis. (1987) 135:1286–1293.
   PubMedGoogle Scholar
• COCHRANE CG, SPRAGG RG, REVAK SD, COHEN AB, MCGUIRE WW: The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. Rev Respir: Dis. (1983) 127:S25–S27.
   Google Scholar
• IDELL S, KUCICH U, FEIN et al: Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am. Rev Respir Dis. (1985) 132:1098–1105.
   PubMed Web of Science ®Google Scholar
• SCHUTTE H, LOHMEYER J, ROSSEAU S et al.: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur. Respir: J. (1996) 9(9):1858–1867.
   PubMedGoogle Scholar
• BAUER TT, MONTON C, TORRES A et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia and controls. Thorax (2000) 55(1):46–51.
   PubMedGoogle Scholar
• BIENIEK K, SZUSTER-CIESIELSKA A, KAMINSKA T et al: Interferon and tumour necrosis factor production during endotovemia in sheep. Arch. Immunol Ther. Exp. (Mrsz) (1998) 46(12):105–111.
   PubMedGoogle Scholar
• RIORDON JR, ROMMENS JM, KEREM BS et al.: Identification of the cystic fibrosis gene; cloning and characterisation of complementary DNA. Science (1989) 245:1066–1072.
   PubMedGoogle Scholar
• BEAR CE, LI CH, KARTNER N et al: Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell (1992) 68(4):809–818.
   PubMed Web of Science ®Google Scholar
• BOUCHER RC, COTTON CU, GATZY JT, KNOWLES MR, YANKASKAS JR: Evidence for reducedand increased Na+permeability in cystic fibrosis human primary cell cultures. j Physiol. Lorid. (1998) 405:77–103.
   Google Scholar
• CISTIC FIBROSIS FOUNDATION: Patient registry 1994 Annual Data Report. Cystic Fibrosis Foundation, Bethesda, MD, USA (1995).
   Google Scholar
• DAVIS PB, DRUMM M, KONSTAN MW: Cystic fibrosis. Am. j Respir: Grit. Care Med. (1996) 154:1229–1256.
   PubMed Web of Science ®Google Scholar
• PILEWSKI JM, FRIZZELL RA: Role of CFTR in airway disease. Physiol Rev (1999) 79W:5215–5255.
   Google Scholar
• KHAN TZ, WAGENER JS, BOST T, MARTINEZ J, ACCURSO FJ, RICHES DW: Early pulmonary inflammation in infants with cystic fibrosis. Am. j Respir Grit. Care Med. (1995) 151:1075–1082.
   PubMed Web of Science ®Google Scholar
• FICK RB: Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis. Chest (1989) 96:158–164.
   PubMed Web of Science ®Google Scholar
• BROWN R, KELLY FJ: Role of free radicals in the pathogenesis of cystic fibrosis. Thorax (1994) 49:738–742.
   PubMed Web of Science ®Google Scholar
• OSIKA E, CAVAILLON J-M, CHADELAT K et al: Distinct sputum cytokine profile in cystic fibrosis and other chronic inflammatory airway disease. Eur. Respir j (1999) 14:339–346.
   PubMedGoogle Scholar
• LEWIS PA: The epidemiology of cystic fibrosis. In: Cystic fibrosis. Hodson ME, Geddes DM (Eds.), Chapman and Hall, London (1995):1–13.
   Google Scholar
• •An epidemiological study of cystic fibrosis.
   Google Scholar
• LAURELL CB, ERIKSSON S: The electrophoretic al-globulin pattern of serum in arantitrypsin deficiency. Scam/. OM. Med. (1963) 15:132–140.
   Google Scholar
• JANOFF A, SLOAN B, WEINBAUM G et al: Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev Respir Dis. (1977) 115:461–478.
   PubMed Web of Science ®Google Scholar
• CARDOSO WV, SEKHON HS, HYDE DM, THURLBECK WM: Collagen and elastin in human pulmonary emphysema. Am. Rev Respir Dis. (1993)147:975–981.
   PubMed Web of Science ®Google Scholar
• KLUT ME, DOERSCHUK CM, VAN EEDEN SF, BURNS AR, HOGG JC: Activation of neutrophils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am. J Respir. Cell Mal Biol. (1993) 9:82–89.
   PubMed Web of Science ®Google Scholar
• TERASHIMA T, KLUT ME, ENGLISH D, HARDS J, HOGG JC, VAN EEDEN SF: Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am. J Respir: Cell Mal Biol. (1999) 20:171–177.
   PubMed Web of Science ®Google Scholar
• HAUTAMAKI RD, KOBAYASHI DK, SENIOR RM, SHAPIRO SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 277:2002–2004.
   PubMed Web of Science ®Google Scholar
• ••An experimental report of studyingmacrophage elastase-mediated emphysema.
   Google Scholar
• RIISE GC, LARSSON S, LOFDAHL C-G, ANDERSSON BA: Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir .j (1994) 7:1673–1677.
   PubMed Web of Science ®Google Scholar
• STOCKLEY RA, BURNETT D: antitrypsin and leukocyte elastase in infected and noninfected sputum. Am. Rev Respir: Dis. (1979) 120:1081–1086.
   PubMed Web of Science ®Google Scholar
• PICCIONI PD, KRAMPS JA, BASBAUM CB, CAUGHEY GH:Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. Chest (1992) 102(5):1470–1476.
   Google Scholar
• SINDER GL, LUCEY EC, CHRISTENSEN TG et al: Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am. Rev Respir: Dis. (1984) 129:155–160.
   PubMedGoogle Scholar
• HALL TS, BREDA MA, BAUMGARTNER WA et al: The role of leukocyte depletion in reducing injury to the lung after hypothermic ischaemia. Curr. Surg. (1987) 44:137–139.
   PubMedGoogle Scholar
• JAESCHKE H, FARHOOD A, SMITH CW: Neutrophils contribute to ischaemid reperfusion injury in rat liver in vivo. FASEB . (1990) 4:3355–3359.
   PubMed Web of Science ®Google Scholar
• GRISHAM MB, HERNANDEZ LA, GRANGER DN: Xanthine oxidase and neutrophil infiltration in intestinal ischaemia. Am. I Physiol (1986) 251:G567–G574.
   Google Scholar
• ITO H, HAMANO K, GOHRA H et al: Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg. Today (1997) 27(3):220–225.
   PubMedGoogle Scholar
• BARTHOLOMEW J, LOWTHER DA: Receptor-mediated binding of leukocyte elastase by chondrocytes. Arthritis Rheum.(1987) 30(4):431–438.
   PubMedGoogle Scholar
• VELVART M, FEHR K: Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Irm (1987) 7:195–202.
   Google Scholar
• MCGOWAN SE, MURRAY JJ: Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. Am. Rev Respir. Dis. (1987) 135(6):1286–1293.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, KEENAN CM, GRANGER DN: Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. I Physiol (1990) 259:G462–G467.
   Google Scholar
• LIU W, OKAJIMA K, MURAKAMI K, HARADA N, ISOBE H, IRIE T: Role of neutrophil elastase in stress-induced gastric mucosal injury in rats. I Lab. OM. Med. (1998) 132:432–439.
   PubMed Web of Science ®Google Scholar
• BERNSTEIN PR, EDWARDS PD, WILLIAMS JC: Inhibitors of human leukocyte elastase. In Progress in Medicinal Chemistry Ellis GP, Luscombe DK (Eds.), Elsevier Science (1994):59–120.
   Google Scholar
• •A thorough review of proteinase inhibitors.
   Google Scholar
• BLANK CA, BRANTLY M: Clinical features and molecular characteristics of al-antitrypsin deficiency. Ann. Allergy (1994) 72:105–121.
   PubMedGoogle Scholar
• •A review of al-antitrypsin deficiency.
   Google Scholar
• WENCKER M, FUHRMANN B, BANIK N, KONIETZKO N: Longitudinal follow-up of patients with al-protease inhibitor deficiency before and during therapy with IV with al-protease inhibitor. Chest (2001) 119(3):737–744.
   PubMed Web of Science ®Google Scholar
• DE WATER R, WILLIAMS LNA, VAN MUIJEN GNP et al: Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am. Rev Respic Dis. (1986) 133:882–890.
   PubMed Web of Science ®Google Scholar
• MCELVANEY NG, DOUJAIJI B, MOAN MJ, BURNHAM MR, WU MC, CRYSTAL RG: Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am. Rev Respir: Dis. (1993) 148:1056–1060.
   PubMed Web of Science ®Google Scholar
• WRIGHT CD, HAVILL AM, MIDDLETON SC et al: Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma. I Pharmacol Exp. Ther. (1999) 289(2):1007–1014.
   PubMed Web of Science ®Google Scholar
• TOMEE JFC, KOETER GH, HIEMSTRA PS, KAUFFMAN HF: Secretory leukocyteprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax (1998) 53(2):114–116.
   PubMedGoogle Scholar
• EDWARDS PD, VEALE CA: Inhibitors of human neutrophil elastase. Expert Opiri. Ther. Patents (1997) 7(1):17–28.
   Web of Science ®Google Scholar
• •A survey of the patent literature 1993-1997.
   Google Scholar
• METZ WA, PEET NP: Inhibitors of human neutrophil elastase as a potential treatment for inflammatory diseases. Expert Opiri. Ther. Patents (1999) 9(7):851–868.
   Web of Science ®Google Scholar
• •A survey of the patent literature 1996-1998.
   Google Scholar
• IMAKI K, OKADA T, NAKAYAMA Y et al: Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors. Bioorg Med. Chem. (1996) 4(12):2115–2134.
   PubMedGoogle Scholar
• KAWABATA K, SUZUKI M, SUGITANI M, IMAKI K, TODA M, MIYAMOTO T: ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. (1991) 177(2):814–820.
   PubMed Web of Science ®Google Scholar
• •The first M vivo and M vitro pharmacological study of ONO-5046.
   Google Scholar
• KAWABATA K, HAGIO T, MATSUMOTO S, YAMADA A, OHNO H: Effect of specific neutrophil elastase inhibitor, ONO-5046 on phorbol myristate acetate-induced acute lung injury in rabbit. Inflamm. Res. (1995) 44\(Supp1.3)5269.
   Google Scholar
• WANG HG, SHIBAMOTO T, MIYAHARA T et al: Effect of ONO-5046, a specific neutrophil elastase inhibitor, on the Phorbol myristate acetate-induced injury in isolated dog luug. Exp. Lung Res. (1999) 25(1):55–67.
   PubMed Web of Science ®Google Scholar
• YASUI S, NAGAI A, AOSHIBA K, OZAWA Y, KAKUTA Y, KONNO K: A specific neutrophil elastase inhibitor (ONO-5046.Na) attenuates LPS-induced acute lung inflammation in the hamster. Eur Respir J. (1995) 8(8):1293–1299.
   Google Scholar
• UCHIBA M, OKAJIMA K, MURAKAMI K, OKABE H, TAKATSUKI K: Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am 1 Physiol (1996) 270(14)1921–L930.
   Google Scholar
• MURAKAMI K, OKAJIMA K, UCHIBA M et al: Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood (1996) 87(2):642–647.
   PubMed Web of Science ®Google Scholar
• GUO L, YAMAGUCHI Y, IKEI S, SUGITA H, OGAWA M: Neutrophil elastase inhibitor (ONO-5046) prevents lung haemorrhage induced by lipopolysaccharide in rat model of cerulein pancreatitis. DV. Dis. Se/. (1995) 40(10):2177–2183.
   PubMedGoogle Scholar
• SAKAMAKI F, ISHIZAKA A, URANO T etal.: Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am. I Respir. Crit. Care Med. (1996) 153(1):391–397.
   Google Scholar
• TAOOKA Y, MAEDA A, HIYAMA K, ISIOKAs S, YAMAKIDO M: Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am. I Respir: Grit. Care Med. (1997) 156(1):260–265.
   PubMed Web of Science ®Google Scholar
• KUBO K, KOBAYASHI T, HAYANO T etal.: Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. I Appl. Physiol. (1994) 77(3):1333–1340.
   Google Scholar
• MURAKAMI K, OKAJIMA K, UCHIBA M, OKABE H, TAKATSUKI K: Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumour necrosis factor production by monocytes. Crit. Care Med. (1996) 24(6):1047–1053.
   PubMed Web of Science ®Google Scholar
• NISHINA K, MIKAWA K, TAKAO Y, MAEKAWA N, SHIGA M, OBATA H: ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Ariesth. Arialg. (1997) 84(5):1097–1103.
   PubMedGoogle Scholar
• KINOSHITA M, ONO S, MOCHIZUKI H: Neutrophils mediate acute lung injury in rabbits: role of neutrophil elastase. Eur. Surg. Res. (2000) 32(6):337–346.
   PubMed Web of Science ®Google Scholar
• DOYLE RL, SZAFLARSKI N, MODIN GW, WIENER-KRONISH JP, MATTHAY MA: Identification of patients with acute lung injury. Am. I Respir: Crit. Care Med. (1995) 152:1818–1824.
   PubMed Web of Science ®Google Scholar
• KANEKO K, KUDOH I, HATTORI S et al.: Neutrophil elastase inhibitor, ONO-5046, modulates acid-induced lung and systemic injury in rabbits. Anesthesiology (1997) 87(3):635–641.
   PubMed Web of Science ®Google Scholar
• HAGIO T, KAWABATA K, MASTUMOTO S, OHNO H: A specific neutrophil elastase inhibitor, ONO-5046Na prevents acid aspiration-induced lung injury in hamster. Mediator Irillamm. (1999) 8\(Suppl. 1):5103.
   Google Scholar
• YAMAMOTO H, KOIZUMI T, KANEKI T, HANAOKA M, KUBO K: Effects of lecithinized superoxide dismutase and a neutrophil elastase inhibitor (ONO-5046) on hyperoxic lung injury in rat. Eur. I Pharmacol (2000) 409(2):179–183.
   PubMed Web of Science ®Google Scholar
• TAKEYAMA K, TAMAOKI J, KONNO K, TAKIZAWA T: Effect of a neutrophil elastase inhibitor on NAP-1/IL-8-induced stimulation of goblet cell secretion in guinea-pig airways. Eur. Respir: 1 (1994) 7\(Supp1.18):76S.
   Google Scholar
• YOSHITAKE K, ISOHAMA Y, KAI H, TAKAHAMA K, MIYATA T: Substance P stimulates the loss of cell-associated high molecular weight glycoconjugates from cultured hamster tracheal epithelial cells through polymorphonuclear leucocytes activation. Biochem. Mol Biol. Int. (1995) 36(5):1009–1016.
   PubMedGoogle Scholar
• SHIMIZU T, TAKAHASHI Y, TAKEUCHI K, MAJIMA Y, SAKAKURA Y: Role of neutrophil elastase in endotoxin-induced mucus hypersecretion in rat nasal epithelium. Ann. Otol. Rhino] Lagrigol. (2000) 109(11):1049–1054.
   PubMedGoogle Scholar
• NOGAMI H, AIZAWA H, MATSUMOTO K et al.: Neutrophil elastase inhibitor, ONO-5046 suppresses ozone-induced airway mucus hypersecretion in guinea-pigs. Eur. I Pharmacol (2000) 390(1-2):197–202.
   PubMed Web of Science ®Google Scholar
• YOSHIMURA K, NAKAGAWA S, KOYAMA S, KOBAYASHI T, HOMMA T: Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. I Appl Physiol (1994) 76(1):91–96.
   PubMedGoogle Scholar
• FUJIMOTO K, KUBO K, SHINOZAKI S et al.: Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep. Respir Physiol (1995) 100(1):91–100.
   PubMedGoogle Scholar
• YAMAZAKI T, OOSHIMA H, USUI A, WATANABE T, YASUURA K: Protective effects of ONO-5046Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann. Thorac. Surg. (1999) 68(6):2141–2146.
   PubMedGoogle Scholar
• TOMIZAWA N, OHWADA S, OHYA T et al.: Effects of neutrophil elastase inhibitor on reperfusion injury in the canine liver. Transplant Proc. (1996) 28(3):1767–1768.
   PubMedGoogle Scholar
• TOMIZAWA N, OHWADA S, OHYA T, KAWASHIMA Y, TAKEYOSHI I, MORISHITA Y: The effect of neutrophil elastase inhibitor in hepatectomy with ischaemia in dogs. I &mg. Res. (1999) 81(2):230–237.
   Google Scholar
• SOEJIMA Y, YANAGA K, NISHIZAKI T, YOSHIZUMI T, UCHIYAMA H, SUGIACHI K: Effect of specific neutrophil elastase inhibitor on ischaemia/reperfusion injury in rat liver transplantation. I &mg. Res. (1999) 86(1):150–154.
   Google Scholar
• CHEN H, CHEN J, SHYR M et al.: Neutrophil elastase inhibitor (ONO-5046) attenuates reperfusion-induced hepatic microcirculatory derangement, energy depletion and lipid peroxidation in rats. Shock (1999) 12(6):462–467.
   PubMedGoogle Scholar
• YAMAGUCHI Y, AKIZUKI E, ICHIGUCHI O et al: Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischaemia-reperfusion in rat liver. Gastroenterology (1997) 112(2):551–560.
   PubMedGoogle Scholar
• LARBRE JP, MOORE AR, DA SILVA JAP, IWAMURA H, IOANNOU Y, WILLOUGHBY DA: Direct degradation of articular cartilage by rheumatoid synovial fluid: Contribution of proteolytic enzymes. Rheumatol. (1994) 21(10):1796–1801.
   Google Scholar
• KAWABATA K, MOORE AR, WILLOUGHBY DA: Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Ann. Rheum. Dis. (1996) 55(4):248–252.
   PubMed Web of Science ®Google Scholar
• IWAMURA H, MOORE AR, WILLOUGHBY DA: Interaction between neutrophil-derived elastase and reactive oxygen species in cartilage degradation. Biochim. Biophys. Acta. (1993) 1156(3):295–301.
   PubMedGoogle Scholar
• MATSUKAWA A, OHKAWARA S, MAEDA T, TAKAGI K, YOSHINAGA M: Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin. Esp. hiimuriol. (1993) 93(2):206–11.
   Google Scholar
• MATSUKAWA A, YOSHIMURA T, MAEDA T, OHKAWARA S, TAKAGI K, YOSHINAGA M: Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. Immunol. (1995) 154(10):5418–5425.
   Google Scholar
• KAKIMOTO K, MATSUKAWA A, YOSHINAGA M, NAKAMURA H: Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell hiimuriol. (1995) 165(1):26–32.
   Google Scholar
• NOZAKI T, SHIBA T, HARA A et al.: The role of neutrophil leukocytic elastase in the formation of alcohol-induced rat gastric mucosal lesiona. j Med. Soc. Toho Univ. (1992) 38(6):1001–1003.
   Google Scholar
• MURAKAMI K, OKAJIMA K, HARADA N, ISOBE H, OKABE H: Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophil in rats. Dig. Dis. Sci. (1998) 43(9):1395–1425.
   Google Scholar
• LUISETTI M, PICCIONI PD, DONNINI M, PEONA V, POZZI E, GRASSI C: Studies of MR889, anew synthetic proteinase inhibitor. Biochem. Biophys. Res. Commun. (1989) 165(2):568–573.
   PubMed Web of Science ®Google Scholar
• BAICI A, PELLOSO R, HORLER D: The kinetic mechanism of inhibition of human leukocyte elastase by MR889, a new cyclic thiolic compound. Biochem. Pharrmacol (1990) 39(5):919–924.
   PubMed Web of Science ®Google Scholar
• RIZZI M, CASALE E, ASCENZI P: Crystal structure and NMR investigationof the serine proteinase inhibitor MR889, a cyclic thiolic compound. I Chem. Soc. Perkin. Trans. 2 (1993) 11:2253–2256.
   Google Scholar
• RIZZI M, CASALE E, CODA A etal.: Serine proteinase inhibition by cyclic thiolic compound Y53025: a crystallographic study. Biochem. Int. (1992) 28(3):385–392.
   Google Scholar
• CARUGO KD, RIZZI M, FASANO M et al: Inhibition of serine proteinases belonging to the chymotrypsin superfamily by the cyclic thiolic compound Y53025: a comparative crystallographic study. Biochem. Biophys. Res. Commun. (1993) 193(1):32–39.
   PubMed Web of Science ®Google Scholar
• MORETTI M, GORRINI M, DONNETTA AM et al: Effects of MR889, a cyclic thiolic neutrophil elastase inhibitor, on rheologic properties of mucus. Life Sci. (1994) 54:463–469.
   PubMed Web of Science ®Google Scholar
• LUISETTI M, STURANI C, SELLA D etal.: MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomised, placebo-controlled clinical trial. Eur. Resp. J (1996) 9(7):1482–1486.
   Google Scholar
• CVETOVICH RJ, CHARTRAIN M, HARTNER JR FW, ROBERGE C, AMANO JS, GRABOWSKI EJJ: An asymmetric synthesis of L-694,458, a human leukocyte elastase inhibitor, via novel enzyme revolution of P-lactum esters. Org. Chem. (1996) 61:6575–6580.
   PubMed Web of Science ®Google Scholar
• VINCENT SH, PAINTER SK, LUFFER-ATLAS D eta].: Orally-active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Drug Metab. Dispos. (1997) 25(8):932–939.
   Google Scholar
• LUFFER-ATLAS D, VINCENT SH, PAINTER SK et al.: Orally-active inhibitors of human leukocyte elastase. III. Identification and characterisation of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. (1997) 25(8):940–952.
   Google Scholar
• DWYER TM, FARLEY JM: Human neutrophil elastase releases two pools of mucinlike glycoconjugate from tracheal submucosal gland cells. Am. I Physiol Lung Cell Ma Physiol (2000) 278:L675–678.
   PubMed Web of Science ®Google Scholar
• GOLDENRING JR, RAY GS, COFFEY JR RJ et al.: Reversible drug-induced oxyntic atrophy in rats. Gastroenterology (2000) 118:1080–93.
   Google Scholar
• OHMOTO K, YAMAMOTO T, HORIUCHI T et al: Design and Synthesis of new orally-active nonpeptide inhibitors of human neutrihpil elastase. I Med. Chem. (2000) 43: 4927–4929.
   PubMed Web of Science ®Google Scholar
• OHMOTO K, OKUMA M, YAMAMOTO T etal.: Design and synthesis of new orally-active inhibitors of human neutrophil elastase. Bioorg. Med. Chem. (2001) 9(5):1307–1323.
   Google Scholar
• ODAGAKI Y, OHMOTO K, MATSUOKA S et al: The crystal structure of the complex of non-peptidic inhibitor of human neutrophil elastase ONO-6818 and porcine pancreatic elastase. Bioorg. Med. Chem. (2001) 9(3):647–651.
   PubMed Web of Science ®Google Scholar
• OHMOTO K, YAMAMOTO T, OKUMA M et al.: Development of orally-active nonpeptide inhibitors of human neutrophil elastase. J. Med. Chem. (2001) 44:1268–1285.
   PubMed Web of Science ®Google Scholar
• SEKIOKA T, HIROTA Y, NAKAO S et al: Pharmacological profile of a novel orally-active neutrophil elastase inhibitor, ONO-6818. Am. J Grit. Care Med. (2001) 163:In Press.
   Google Scholar
• KUBO T, OKAZAKI H, KUROMIYAA et al: AE-3763, a novel inhibitor of neutrophil elastase (1): Biochemical and pharmacological properties of AE-3763. fpri. Pharmacol (2001) 85:199.
   Google Scholar
• KUROMIYA A, OKAZAKI H, KUBO T et al: AE-3763, a novel inhibitor of neutrophil elastase (2): Effects of AE-3763 on acute organ failure models. fpri. Pharmacy] (2001) 85:199.
   Google Scholar
• SHINGUH Y, IMAI K, YAMAZAKI A et al: Biochemical and pharmacological characterisation of FK706, a novel elastase inhibitor. Eur. Pharmacol (1997) 337(1):63–71.
   PubMed Web of Science ®Google Scholar
• BORENFREUND E, PUERNER JA: Short-term quantitative in vitro cytotoxicity assay involving an S-9 activating system. Cancer Lett. (1987) 34(3):243–248.
   PubMedGoogle Scholar